Low-CSD melanoma is likely to arise as a result of aberrations of BRAF mutation (45%) rather than RAS and NRAS mutations, which are identified in high-CSD exposure, in 15–30% and 15% of cases, respectively [24,25,56] (Table 3). This evidence concerns the gene NRAS and melanoma.